Top Markets
Coin of the day
Hanmi Science Co., Ltd. Hanmi Science Co., Ltd.

Hanmi Science Co., Ltd.

008930
Rank in Stocks #6567
Hanmi Science Co., Ltd. operates through its subsidiaries to produce and... Hanmi Science Co., Ltd. operates through its subsidiaries to produce and distribute pharmaceutical products both within South Korea and internationally. The company's research and development initiatives primarily target treatments for diabetes and various types of cancer. Its extensive product line further includes active pharmaceutical ingredients, general therapeutic drugs, nutritional supplements, and a variety of health-related goods and services. Additionally, it manages an online pharmacy platform and provides automated systems for pharmaceutical administration. The firm, which was initially established as Hanmi Holdings Co., Ltd. in 1973, adopted its current name, Hanmi Science Co., Ltd., in March 2012, and its corporate headquarters are situated in Seoul, South Korea.
Share Price
$29.11
Market Cap
$1.97B
Change (1 day)
-5.18%
Change (1 year)
-2.35%
Country
KR
Trade Hanmi Science Co., Ltd. (008930)

Category

Revenue for Hanmi Science Co., Ltd. (008930)
Revenue in Aug 2026 TTM: 0
According to Hanmi Science Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hanmi Science Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$410.98B -
US
- -
US
$254.25B -
US
- -
US
$3.67B -
AU